Revision as of 20:38, 8 March 2013 editAddbot (talk | contribs)Bots2,838,809 editsm Bot: Migrating 3 interwiki links, now provided by Wikidata on d:q187487← Previous edit | Latest revision as of 01:51, 19 August 2023 edit undoOAbot (talk | contribs)Bots439,234 editsm Open access bot: doi updated in citation with #oabot. | ||
(29 intermediate revisions by 22 users not shown) | |||
Line 1: | Line 1: | ||
{{Correct title|7,12-Dimethylbenzanthracene|reason=bracket|edit=substitution}} | |||
{{DISPLAYTITLE:7,12-Dimethylbenz(''a'')anthracene}} | |||
{{chembox | {{chembox | ||
| Watchedfields = changed | | Watchedfields = changed | ||
| Name=7,12-Dimethylbenzanthracene | |||
| verifiedrevid = |
| verifiedrevid = 477226290 | ||
|Reference=<ref> at ]</ref> | | Reference=<ref> at ]</ref> | ||
|ImageFile1=DMBA.png | | ImageFile1=DMBA.png | ||
|ImageSize1=200px | |||
|ImageFile2=7,12-Dimethylbenz(a)anthracene_ballstick.png | | ImageFile2=7,12-Dimethylbenz(a)anthracene_ballstick.png | ||
| PIN = 7,12-Dimethyltetraphene | |||
|ImageSize1=200px | |||
| OtherNames = 7,12-Dimethylbenzophenanthrene<br />7,12-Dimethylbenzanthracene<br />7,12-Dimethyltetraphene<br />1,4-Dimethyl-2,3-benzophenanthrene | |||
|IUPACName=7,12-dimethylbenzophenanthrene | |||
|OtherNames= | |||
|Section1={{Chembox Identifiers | |Section1={{Chembox Identifiers | ||
⚫ | | CASNo=57-97-6 | ||
⚫ | | |
||
⚫ | | CASNo_Ref = {{cascite|correct|CAS}} | ||
| Beilstein = 1912135 | |||
⚫ | | ChEBI_Ref = {{ebicite|correct|EBI}} | ||
⚫ | | ChEBI = 254496 | ||
⚫ | | ChEMBL_Ref = {{ebicite|correct|EBI}} | ||
⚫ | | ChEMBL = 329673 | ||
⚫ | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 5779 | | ChemSpiderID = 5779 | ||
| Gmelin = 263937 | |||
| KEGG = C19488 | |||
⚫ | | PubChem=6001 | ||
| RTECS = CW3850000 | |||
| UNNumber = 3077 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = F05B6S0395 | |||
| InChI = 1/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3 | | InChI = 1/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3 | ||
| InChIKey = ARSRBNBHOADGJU-UHFFFAOYAX | | InChIKey = ARSRBNBHOADGJU-UHFFFAOYAX | ||
⚫ | | ChEMBL_Ref = {{ebicite|correct|EBI}} | ||
⚫ | | ChEMBL = 329673 | ||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChI = 1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3 | | StdInChI = 1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3 | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChIKey = ARSRBNBHOADGJU-UHFFFAOYSA-N | | StdInChIKey = ARSRBNBHOADGJU-UHFFFAOYSA-N | ||
⚫ | | CASNo=57-97-6 | ||
⚫ | | |
||
⚫ | | |
||
⚫ | | |
||
⚫ | | ChEBI = 254496 | ||
| SMILES = c32c(c1ccccc1c(c2ccc4c3cccc4)C)C | | SMILES = c32c(c1ccccc1c(c2ccc4c3cccc4)C)C | ||
}} | }} | ||
|Section2={{Chembox Properties | |Section2={{Chembox Properties | ||
| |
| C=20 | H=16 | ||
| Appearance= | |||
| MolarMass=256.34104 | |||
| |
| Density= | ||
| MeltingPtC=122 to 123 | |||
| Density= | |||
| BoilingPt= | |||
| MeltingPt=122–123 °C | |||
| |
| Solubility= | ||
| Solubility= | |||
}} | }} | ||
|Section3={{Chembox Hazards | |Section3={{Chembox Hazards | ||
| |
| MainHazards=T (Toxic) | ||
| |
| FlashPt= | ||
| AutoignitionPt = | |||
| Autoignition= | |||
| |
| GHSPictograms = {{GHS07}}{{GHS08}} | ||
| GHSSignalWord = Danger | |||
| SPhrases={{S53}} {{S36/37}} {{S45}} | |||
| HPhrases = {{H-phrases|302|350}} | |||
| PPhrases = {{P-phrases|201|202|264|270|281|301+312|308+313|330|405|501}} | |||
| NFPA-H = 2 | |||
| NFPA-R = 0 | |||
| NFPA-F = 0 | |||
| NFPA-S = | |||
}} | }} | ||
}} | }} | ||
'''7,12-Dimethylbenz |
'''7,12-Dimethylbenzanthracene''' ('''DMBA''') is an ] and a powerful organ-specific laboratory ].<ref>{{cite journal |author=Miyata M |author2=Furukawa M |author3=Takahashi K |author4=Gonzalez FJ |author5=Yamazoe Y |title=Mechanism of 7, 12-Dimethylbenzanthracene-Induced Immunotoxicity: Role of Metabolic Activation at the Target Organ |journal=Jpn J Pharmacol |date=2001 |volume=86 |issue=3 |pages=302–309 |doi=10.1254/jjp.86.302 |pmid=11488430 |doi-access=free }}</ref> DMBA is widely used in many research laboratories studying cancer. DMBA serves as a ]. ] can be induced with treatments of ] (TPA) in some models of two-stage carcinogenesis.<ref>{{cite journal | author = Sung YM | author2 = He G | author3 = Fischer, SM | date = 2005 | title = Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development | journal = Cancer Res | volume = 65 | issue = 20 | pages = 9304–9311 | doi=10.1158/0008-5472.can-05-1015| pmid = 16230392 | doi-access = }}</ref> This allows for a greatly accelerated rate of tumor growth, making many cancer studies possible. | ||
==References== | ==References== | ||
Line 53: | Line 66: | ||
] | ] | ||
] | ] | ||
] | |||
] |
Latest revision as of 01:51, 19 August 2023
The correct title of this article is 7,12-Dimethylbenzanthracene. The substitution of any brackets is due to technical restrictions.Names | |
---|---|
Preferred IUPAC name 7,12-Dimethyltetraphene | |
Other names
7,12-Dimethylbenzophenanthrene 7,12-Dimethylbenzanthracene 7,12-Dimethyltetraphene 1,4-Dimethyl-2,3-benzophenanthrene | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
Beilstein Reference | 1912135 |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.000.326 |
Gmelin Reference | 263937 |
KEGG | |
PubChem CID | |
RTECS number |
|
UNII | |
UN number | 3077 |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C20H16 |
Molar mass | 256.348 g·mol |
Melting point | 122 to 123 °C (252 to 253 °F; 395 to 396 K) |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards | T (Toxic) |
GHS labelling: | |
Pictograms | |
Signal word | Danger |
Hazard statements | H302, H350 |
Precautionary statements | P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, P501 |
NFPA 704 (fire diamond) | 2 0 0 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
7,12-Dimethylbenzanthracene (DMBA) is an immunosuppressor and a powerful organ-specific laboratory carcinogen. DMBA is widely used in many research laboratories studying cancer. DMBA serves as a tumor initiator. Tumor promotion can be induced with treatments of 12-O-tetradecanoylphorbol-13-acetate (TPA) in some models of two-stage carcinogenesis. This allows for a greatly accelerated rate of tumor growth, making many cancer studies possible.
References
- 7,12-Dimethylbenz(a)anthracene at Sigma-Aldrich
- Miyata M; Furukawa M; Takahashi K; Gonzalez FJ; Yamazoe Y (2001). "Mechanism of 7, 12-Dimethylbenz[a]anthracene-Induced Immunotoxicity: Role of Metabolic Activation at the Target Organ". Jpn J Pharmacol. 86 (3): 302–309. doi:10.1254/jjp.86.302. PMID 11488430.
- Sung YM; He G; Fischer, SM (2005). "Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development". Cancer Res. 65 (20): 9304–9311. doi:10.1158/0008-5472.can-05-1015. PMID 16230392.